A detailed history of Jump Financial, LLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 85,838 shares of CRDF stock, worth $229,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,838
Holding current value
$229,187
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.22 - $5.89 $190,560 - $505,585
85,838 New
85,838 $190,000
Q2 2022

Aug 09, 2022

SELL
$1.17 - $2.61 $48,672 - $108,576
-41,600 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$2.11 - $7.25 $87,776 - $301,600
41,600 New
41,600 $103,000
Q3 2021

Nov 12, 2021

SELL
$5.01 - $7.58 $220,941 - $334,278
-44,100 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$6.65 - $10.04 $293,265 - $442,763
44,100 New
44,100 $293,000

Others Institutions Holding CRDF

About Cardiff Oncology, Inc.


  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $116M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.